Xencor, Inc.
Heterodimeric antibodies that bind somatostatin receptor 2
Last updated:
Abstract:
The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind somatostatin receptor 2 (SSTR2).
Status:
Grant
Type:
Utility
Filling date:
24 Apr 2019
Issue date:
18 Jan 2022